Select another
Cluster
Join us on Twitter Join us on Linkedin Become a member Subscribe to the newsletter

Luxembourg BioHealth Cluster

 

The Luxembourg BioHealth Cluster is a young emerging Cluster aiming to reinforce and capitalise on the National Strategy developed by the Government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine, and to enhance the Grand Duchy's reputation as a recognised and attractive environment for biomedical research, development, innovation (RDI) and business.

Our members are R&D companies, public research organisations, laboratories, hospitals and other actors (patients associations, providers of capital and services…) based in Luxembourg whose activities are related to Health Sciences and Technologies. With a principal focus on molecular diagnostics, the Cluster’s umbrella also covers other RDI/business domains that are key elements in an integrated patient-based personalised medicine approach, such as new therapeutics, bioinformatics, medical device and telemedicine. Supporting this dynamic and steadily growing biocommunity is our main objective. Therefore, we provide our members with a portfolio of added-value activities and services to support them in their daily RDI and/or business challenges and to increase their national and international visibility.

     
 

News

  • 23-01-2015 7 jours pour construire les fondations d'une organisation innovante

    De la définition d'une stratégie d'innovation au lancement d'un produit-service innovant, découvrez le programme 2015 de la formation en gestion de l'innovation proposée par Luxinnovation, la LSC (Luxembourg School of Commerce) et la Chambre des Métiers. Le premier module de la formation aura lieu le 3 mars.

  • 22-01-2015 LCSB and Maastricht University investigate environmental risk factors for Parkinson’s disease

    Developing Parkinson’s disease not only depends on our genetic makeup, but is also influenced by our lifestyle and the exposure to chemicals in our environment. On 22 January 2015, Prof Rudi Balling from the Luxembourg Centre for Systems Biology (LCSB) of the University of Luxembourg and Prof Jos Kleinjans from Maastricht University, The Netherlands, have signed a collaboration agreement to study and predict potential toxic effects of chemicals in relation to neurodegenerative disease risks.

  • 21-01-2015 New Cluster website section: Partnering opportunities

    Technology offers and requests, published by companies and laboratories from all over Europe through the Enterprise Europe Network, can help you find a specific technology or innovation that allows you to further develop your business